Thursday, October 15, 2026
ExploreSearch
Finance Via News
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· March 22, 2026

Crypto News: Pepeto Updates Binance Level Exchange And Ethereum Price Prediction Aims $7,500 Despite Crypto Crash

View original at globenewswire.com
Crypto News: Pepeto Updates Binance Level Exchange And Ethereum Price Prediction Aims $7,500 Despite Crypto Crash Dubai, UAE, March 22, 2026 (GLOBE NEWSWIRE) -- The Pepeto team just hit a big milestone on its Binance level exchange, finishing the order book engine and the multi chain liquidity system as the project mov…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Ethereum price will reach $7,500 by end of 2026

    60% confidence

  • Multiple research teams predict Ethereum price between $4,500 and $7,500 for end of 2026

    60% confidence

  • The platform runs zero cost swaps on Ethereum, cuts out the gas fees that make small trades pointless on other DeFi platforms, moves coins between Ethereum, BNB Chain, and Solana instantly with no bridging cost, and runs AI checks on every listed token looking for honeypot tricks, hidden mint tools, and rug pull code before it can be traded

    60% confidence

  • Pepeto reaching $100 million market cap from presale pricing gives over 50x returns

    60% confidence

  • Ethereum price at $7,500 gives ETH holders 3.5x returns from current levels

    60% confidence

  • Extreme fear lasting 46 straight days has only happened four times since 2018, and every time marked the start of that cycle's biggest recovery

    60% confidence

  • Wider analyst range for Ethereum goes from $4,500 to $10,000 as Glamsterdam upgrade and ETF inflows lift price

    60% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biopharma Catalyst Cluster: Late-Stage Readouts and Regulatory Milestones
October 2026 brings a dense run of Phase 3 wins (ALOFT-IPF, RESTORE-3), new data presentations (Roche, Bayer, Lilly, Vertex, Galderma) and regulatory steps (FDA acceptance of Roche's vamikibart BLA, Scholar Rock's EMA resubmission). The next big catalyst is the ivonescimab FDA PDUFA date on 2026-11-14. Obesity combination studies (REDEFINE 4, TOGETHER-PsO) and the 2027 Maritime-1 completion point to more catalysts ahead. QAIAx's speculative AI-linked trial claims (the QIII pilot, targeted for 2027) are an unrelated micro-cap sideshow with weak evidence, and have little in common with the large-cap pipeline news.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,377 source documents archived
Query this data → isubstrate.com
Crypto News: Pepeto Updates Binance Level Exchange And Ethereum Price Prediction Aims $7,500 Despite Crypto Crash — Source | Via News | Finance Via News